Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2010-03-02
2011-10-25
Henley, III, Raymond (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S315000, C514S579000, C514S613000
Reexamination Certificate
active
08044058
ABSTRACT:
Disclosed is the use of merocyanine derivatives of formulaQ is hydrogen; C1-C22alkyl; —OH; —OR7; —NR7R8; or —N═R9;R1is hydrogen; C1-C22alkyl; —OR7, —SR7; —NR7R8; C1-C22alkyl; C2-C12alkenyl; C2-C12alkinyl; C3-C12cycloalkyl; C3-C12cycloalkenyl; C7-C12aralkyl; C1-C12heteroalkyl, C2-C11heteroaralkyl; C6-C10aryl; or C1-C9heteroaryl;R4is cyano; COR7, COOR7; CONR7R8; SO2(C6-C12)aryl; C2-C12alk-1-enyl; C3-C12cycloalk-1-enyl; C2-C12alk-1-inyl; C2-C12heteroalkyl; C3-C5heterocycloalkyl; C6-C10aryl; or C1-C9heteroaryl;R5is —COR7; —COOR7; —OR7; —SR7, —NHR7, —NR7R8; C1-C22alkyl; C2-C12alkenyl; C2-C12alkinyl; C3-C12cycloalkyl; C3-C12cycloalkenyl; C7-C12aralkyl; C1-C12alkylphenyl; C1-C12alkoxy-C6-C10aryl; C1-C12heteroalkyl; C2-C11heteroaralkyl; C3-C12cycloheteroalkyl; C6-C10aryl; C1-C12alkoxy-C6-C10aryl; or C1-C9heteroaryl;R6is hydrogen; C1-C22alkyl; C1-C22alkoxy; or COR7;R7and R8independently from each other are hydrogen; C1-C22alkyl; C2-C12alkenyl; C2-C12alkinyl; C3-C12cycloalkyl; C3-C12cycloalkenyl; —(CH2)tCOOH; C7-C12aralkyl; C1-C12heteroalkyl; C2-C11heteroaralkyl; C6-C10aryl; C1-C9heteroaryl; Si—R10R11R12; Si(OR10)(OR11)(OR12); SiR10(OR11)(OR12); SiR10R11(OR12); —(CH2)u—O—(CH2)v—SiR10R11R12; or a radical X-Sil;t, u and v, independently from each other are a number from 1 to 5;R9is a (C1-C6)alkylidene radical;R10, R11, R12independently form each other are C1-C22alkyl;X is a linker;for protecting of human hair and skin against the damaging effect of UV radiation.
REFERENCES:
patent: 4457911 (1984-07-01), Conner et al.
patent: 5380700 (1995-01-01), Miyazaki et al.
patent: 5806834 (1998-09-01), Yoshida
patent: 7772242 (2010-08-01), Wagner et al.
patent: 2002/0187114 (2002-12-01), Mankovitz
patent: 2004/0132796 (2004-07-01), Valla et al.
patent: 2005/0255055 (2005-11-01), Wagner et al.
patent: 947185 (1956-08-01), None
patent: 10240863 (2004-03-01), None
patent: 2409203 (2005-06-01), None
patent: 0234710 (2002-05-01), None
patent: 03068183 (2003-08-01), None
patent: 2004006878 (2004-01-01), None
patent: 2004075871 (2004-09-01), None
patent: 2005012228 (2005-02-01), None
patent: 2005080341 (2005-09-01), None
E.N. Dozorova et al., Translation of Khimiya Geterotsiklicheskikh Soedinenii, vol. No. 8, pp. 1109-1114, (Aug. 1988).
Chiara B. Vicentini, et al., Heterocycles, vol. 53, No. 6, pp. 1285-1292, (Feb. 2000).
Von Willi Kantlehner, et al., chemiker-Zeitung, vol. 114, No. 5, pp. 176-178, (1990).
Bienewald Frank
Ehlis Thomas
Haase Jürg
Herzog Bernd
Wagner Barbara
BASF SE
Henley III Raymond
Loggins Shiela A.
LandOfFree
Merocyanine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Merocyanine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Merocyanine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4269110